Condition: Renal Insufficiency, Chronic · Polycystic Kidney Diseases · Proteinuria · Sponsor: Gødstrup Hospital
A randomized, placebo-controlled, double-blinded crossover study will be conducted. Fourteen patients with polycystic kidney disease (PKD) and 29 patients with proteinuric kidney disease will receive ketone bodies (Ketone-IQ) and placebo in a randomized order. Each treatment period is four weeks. There will be a wash-out period of two weeks in between treatment periods. Effect variables will be measured in the last day of each treatment period.
This description comes directly from the study's public registry record.
Trine Z Lyksholm, MD · 78432534 · trizur@rm.dk
Always discuss trial participation with your own doctor first.
| University Clinic in Nephrology and Hypertension, Gødstrup Region Hospital | Herning, Jutland, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06867471